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Abstract
Autosomal recessive polycystic kidney disease (ARPKD), usually considered to be a genetically 
homogeneous disease caused by mutations in PKHD1, has been associated with ciliary 
dysfunction. Here, we describe mutations in the DAZ interacting protein 1-like (DZIP1L) gene in 
patients with ARPKD, findings we have further validated by loss-of-function studies in mice and 
zebrafish. DZIP1L localizes to centrioles and at the distal end of basal bodies, and interacts with 
septin2, a protein implicated in maintenance of the periciliary diffusion barrier at the ciliary 
transition zone. Consistent with a defect in the diffusion barrier, we found that the ciliary 
membrane translocation of the PKD proteins, polycystin-1 and −2, is compromised in DZIP1L 
mutant cells. Together, these data provide the first conclusive evidence that ARPKD is not a 
homogeneous disorder, and establishes DZIP1L as a second gene involved in its pathogenesis.
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INTRODUCTION
Polycystic kidney disease (PKD) is the most common form of heritable kidney disease. In 
contrast to the later onset of autosomal dominant PKD (ADPKD), the autosomal recessive 
form (ARPKD) manifests perinatally or in childhood with enlarged kidneys1, and arterial 
hypertension in most surviving children2. Hepatic ductal plate malformation (DPM) can be 
detected histologically, but often only manifests clinically with increasing age.
In addition to ADPKD and ARPKD, cystic kidney disease is a feature of some syndromic 
ciliopathies, which arise from dysfunctional primary cilia3. Cilia are microtubule-based 
organelles that project from the surface of most vertebrate cells, and function in chemo- and 
mechano-sensation and fluid transport. The ciliary axoneme is anchored by the centriole-
derived basal body, and is ensheathed by the ciliary membrane. Located between the basal 
body and axoneme, the transition zone forms a diffusion barrier that modulates the selective 
passage of proteins to and from the cilium4–6.
PKHD1, encoding fibrocystin (FPC)/polyductin, is widely believed to be the only ARPKD 
gene7. Like the two ADPKD proteins, polycystin-1 and −2 (PC1 and 2), FPC has been 
shown to localize to cilia8,9 and associate with the PC1/2 complex, which has long been 
thought to regulate calcium (Ca2+) signalling in response to urine flow10–12. However, the 
role of PC1/2 complex in Ca2+ signaling and the theory that primary cilia are Ca2+-
responsive mechanosensors has recently been refuted13–15. Thus, the precise mechanisms 
underpinning PKD remain elusive.
Here, we report the identification of a second ARPKD locus, with homozygous mutations in 
the cilia-related gene DZIP1L in seven patients from four families. We further validated 
these findings in mouse and zebrafish models. We show that DZIP1L localizes to centrioles 
and at the distal end of the basal body, and interacts with septin2 (SEPT2), a protein 
involved in maintenance of the diffusion barrier at the transition zone. Consistent with these 
data, we found that in DZIP1L deficient primary cilia, PC1 and PC2 show altered 
distribution along the ciliary membrane.
RESULTS
DZIP1L is a new ARPKD gene
In two unrelated consanguineous multiplex pedigrees (B16 and A3533) with a total of five 
children affected by ARPKD, mutations in known PKD genes were excluded by linkage 
analysis and sequencing (Fig. 1; data not shown). Genome-wide SNP analysis in DNA from 
parents and all affected children revealed a single overlapping homozygous peak, suggesting 
a new disease locus on chromosome 3q22, in a 7.5Mb region of genomic DNA (Fig. 1). By 
whole-exome sequencing (WES) and subsequent Sanger sequencing, we identified different 
homozygous missense DZIP1L mutations that segregated with disease in each family 
(Family B16: c.269C>T (p.Ala90Val); Family A3533: c.273G>C, (p.Gln91His); Accession 
number: NM_173543.2) (Fig. 1, Supplementary Fig. 1 and Supplementary Table 1). 
Interestingly, these mutations affect adjacent evolutionarily conserved residues of DZIP1L, 
and are bioinformatically predicted to be pathogenic (Table 1). No further convincing 
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variants were identified in the candidate region in these pedigrees. All three affected 
individuals in family B16 showed enlarged polycystic kidneys with reduced cortico-
medullary differentiation, and developed arterial hypertension early during childhood. A 
comparable clinical course was observed in the two affected girls in family A3533 (Table 1).
Next, we analysed DZIP1L by Sanger sequencing in 218 unrelated patients with suspected 
ARPKD or sporadic PKD, the majority of whom had tested negative for mutations in known 
cystoprotein genes. A further 1330 patients with a PKD phenotype (n=525) or a 
nephronopthisis (NPHP)-related complex ciliopathy (n=805) were analyzed by next-
generation sequencing (NGS), mainly targeted multi-gene panel testing16. Thereby, we 
identified different homozygous protein truncating DZIP1L mutations (c.463C>T; 
(p.Gln155*) and c.1061_1062del; (p.Glu354Alafs*39)) in two additional unrelated 
consanguineous pedigrees, B155 and B8031, with hallmarks of ARPKD (Fig. 1, Table 1, 
Supplementary Fig. 1).
DZIP1L encodes a 767 amino acid (aa) protein containing a C2H2-type zinc finger motif (aa 
166–189) and a series of coiled-coil domains (aa 205–406) (Supplementary Fig. 2), and 
previous overexpression studies showed localization to the ciliary base17. In zebrafish and 
mice, we and others have implicated the paralogue Dzip1 in hedgehog (HH) signalling and 
ciliogenesis18–22, but there is little known about Dzip1l function in any organism.
A Dzip1l loss-of-function mouse model
In a recessive N-ethyl-N-nitrosourea (ENU) mutagenesis screen23, we identified a mouse 
mutant (warpy or wpy) with widespread embryonic dysmorphologies. Linkage analysis 
mapped the mutation to a 64 Mb region on chromosome 9, and subsequent WES identified 8 
homozygous mutations only one of which, a nonsense mutation in the region encoding the 
coiled-coil domains of Dzip1l (c.1123C>T; p.Gln375*; Accession number: NM_028258.4), 
was within the linkage interval (Supplementary Fig. 3a). On a C57BL/6:C3H mixed or a 
pure C57BL/6 background, homozygous Dzip1lwpy/wpy mutants displayed a range of 
phenotypes, including highly penetrant polydactyly of all four limbs and craniofacial defects 
(Fig. 2), including full or partial cleft palate and bilateral cleft lip (Fig. 2f–i). Gross eye 
abnormalities were evident in 67% (n=30/45) of embryos scored from 13.5 days post coitum 
(dpc) on, in some cases manifesting as internalised eyes (Fig. 2j,k). Homozygous C57BL/
6:C3H mutant embryos were recovered at roughly the expected Mendelian frequency at 
mid-gestation (23.3% at 10.5dpc, n=66/283), but although some embryos were recovered up 
to 18.5dpc, viability was decreased at later stages.
These phenotypes, in particular polydactyly, suggested a defect in HH signalling, a pathway 
regulated by the primary cilium24. Accordingly, we saw expansion of Hoxd13 and gremlin 
(Grem1) expression into the anterior fore- and hindlimb bud of 11.5dpc Dzip1lwpy/wpy 
embryos (n=3; Supplementary Fig. 3b; hindlimb data not shown), suggesting a decrease in 
the repressor form of the GLI3 transcription factor that mediates HH signalling in the 
limb25. Consistent with cilia and GLI3 regulating HH signalling downstream of ligand, the 
expression of sonic hedgehog (Shh) appeared unaltered in mutant limbs. Interestingly, while 
patched1 (Ptch1) was not consistently altered, another universal downstream marker of HH 
signalling, Gli1, showed subtle but consistent ectopic anterior expression (Supplementary 
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Fig.3b). We next assessed the ability of Dzip1lwpy/wpy mouse embryonic fibroblasts (MEFs) 
to respond to the HH agonist SAG, and showed an attenuated response relative to wild-type 
MEFs, as measured by qRT-PCR for Gli1 (Supplementary Fig.3d). In contrast to the limb 
and MEFs, we saw no evidence of altered HH signalling across the dorsal-ventral axis of the 
neural tube in Dzip1lwpy/wpy embryos, as assessed by staining for markers of SHH-
dependent neuronal populations, regardless of the anterior-posterior level of the sections 
(n=2 for Shh, 3 for other markers; Supplementary Fig. 3c). Our data suggest tissue-specific 
effects on HH signalling in Dzip1lwpy/wpy embryos, with gene expression changes in the 
limb consistent with polydactyly.
Dzip1lwpy/wpy mutants develop cystic kidney disease
On a mixed C57BL/6:C3H background, Dzip1lwpy/wpy embryos display cystic kidneys from 
15.5dpc (data not shown). To analyse the postnatal progression of this phenotype, we 
crossed the mice to an outbred CD1 background, and after 4 generations, were able to 
recover live mice. These mice still displayed limb defects, albeit less severe than the inbred 
embryos, but gross facial clefting phenotypes were rare. This suggests that some of the 
dysmorphologies seen in the Dzip1lwpy/wpy embryos, but not in ARPKD patients, may be 
due to genetic background effects. Homozygous mutants were born at the expected 
Mendelian frequency (25.2%, n=30/119), but showed a generalised failure to thrive, and all 
were sacrificed by postnatal day (P)21.
Histological analysis of kidney sections following at least four crosses to CD1 revealed a 
highly penetrant progressive cystic kidney phenotype (Fig. 3). Late in embryogenesis, the 
most obvious cysts were located toward the renal cortex (Fig. 3a,b; n=4 for 15.5dpc). At P0 
(n=6) we observed marked dilatations throughout the medullary region that stained positive 
for the collecting duct marker Aquaporin2 (Aqp2) (Fig. 3c–f,h,j). Some more cortical cysts 
stained positive for a proximal tubule marker (LTL-biotin) (Fig. 3e,f,i). The phenotype 
increased in severity with age, and P21 kidneys were massively cystic and larger than wild-
type when corrected for body weight (Fig. 3k–m; n=3). Consistent with ARPKD in humans, 
we also observed subtle signs of DPM (excess of bile ducts) in the livers of Dzip1lwpy/wpy 
mice at P21 (n=2) (Fig. 3n–q and Supplementary Fig. 4). Hepatic fibrosis was not detected, 
likely due to the young age of these mice.
Inactivation of zebrafish dzip1l causes phenotypes consistent with ciliary dysfunction
The single orthologue of DZIP1L in the zebrafish genome (Accession number: 
NM_0010372277.1; Supplementary Fig. 2) is maternally expressed (Supplementary Fig. 
5a), and 1 day post-fertilization (dpf) embryos express fairly ubiquitous low levels of dzip1l, 
with a more discrete accumulation in the embryonic kidneys - the pronephric ducts 
(Supplementary Fig. 6a,b). Unlike the solitary primary cilium in mammalian kidney cells, 
zebrafish pronephric duct cells harbour motile cilia, with the mid-section of each duct 
containing cells bearing mono-motile cilia interspersed with multiciliated cells (MCCs). 
dzip1l expression was observed in the mid-section of the pronephric ducts in a pattern 
consistent with the MCCs (Supplementary Fig. 6b), and in the nasal placodes, another tissue 
populated by MCCs (Supplementary Fig. 6c).
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We next used four different antisense morpholino oligonucleotides (one translation blocking 
and three splice inhibitory) to knockdown dzip1l function, with all four producing largely 
identical cilia-related phenotypes. From 2 dpf on, dzip1l morphants presented a slight body 
axis curvature, hydrocephalus and defects in otolith formation in the inner ear 
(Supplementary Fig. 6d–g). Otolith defects were observed in 12–15% of translation blocking 
(n=258) and splice inhibitory morpholino (n=584) injected embryos, but not in controls 
(n=195) (Supplementary Fig. 6e,g,i). Despite the ciliary dysfunction phenotypes, no obvious 
alterations in Hh signalling were detected in 1–2 dpf dzip1l morphant embryos by in situ 
hybridization for ptc1, eng1 and nkx2.2b expression (data not shown).
To investigate defects in glomerular and pronephric tubules, we injected the dzip1l 
translation blocking morpholino into Tg(wt1b::GFP) transgenic embryos that express GFP 
in the pronephros26. Approximately 10% of morphant embryos displayed glomerular cysts 
(n=100) (Supplementary Fig. 6h,i). Specificity of the dzip1l morphant phenotypes was 
demonstrated by co-injection of embryos with the translation blocking morpholino and wild-
type dzip1l mRNA. 85% of the morphants showed severe morphological defects, compared 
to 36% of the mRNA co-injected embryos (Supplementary Fig. 6j). mRNA rescue was 
confirmed with a second (splice blocking) morpholino (data not shown). RT-PCR analysis 
confirmed mis-splicing (Supplementary Fig. 5b–d).
We next generated a mutant dzip1l allele using CRISPR/Cas9 technology, targeting exons 2 
and 13 with two separate guide RNAs to induce a large deletion (Supplementary Fig. 5e,f). 
Embryos homozygous for this deletion showed highly penetrant defects in otolith 
deposition, but no additional morphological abnormalities (Supplementary Fig. 5g). Since 
dzip1l is expressed maternally, we raised zygotic mutants to adulthood, and bred them to 
obtain maternal-zygotic mutant embryos. Like the zygotic mutants, maternal-zygotic dzip1l 
deficient embryos exhibited defective otolith deposition, but no other overt morphological 
changes (data not shown).
DZIP1L localizes to centrioles and to the distal end of basal bodies
To investigate the subcellular localization of endogenous DZIP1L we used two commercial 
antibodies, one raised to the C-terminus of DZIP1L (Sigma-Aldrich), and one to the entire 
protein (Abnova). Both antibodies stained centrioles and basal bodies in mouse kidney inner 
medullary collecting duct (IMCD3) cells, MEFs and human dermal fibroblasts (Fig. 4a–i 
and Supplementary Fig. 7a,c,f and data not shown). Furthermore, DZIP1L remained 
localized to the centrioles throughout the cell cycle, even when cilia are disassembled during 
mitosis (Fig. 4e–i). The mother centriole, from which the basal body is derived, acquires 
sub-distal and distal appendages, with distal appendages or transition fibres anchoring the 
basal body to the ciliary membrane at the transition zone27. DZIP1L staining overlaps with 
both sub-distal (ODF2) and distal (CEP164) appendage markers in IMCD3 cells (Fig. 4c,d). 
This suggests that DZIP1L localizes to the distal end of the mother centriole, possibly at the 
site where the transition zone forms. Consistent with this, DZIP1L co-localizes with the 
transition zone protein tectonic1 (TCTN1) in ciliated human fibroblasts (Fig. 4j). This was 
confirmed in retinal pigment epithelium (RPE-1) cells by superresolution microscopy (3D-
SIM) that improved resolution (by a factor of 2 in all dimensions; to give ∼120 nm 
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resolution laterally, xy), and revealed that DZIP1L and TCTN1 indeed localize in close 
proximity of each other (Fig. 4k).
As expected, the C-terminal DZIP1L antibody (Sigma) did not detect specific staining in 
mutant Dzip1lwpy/wpy MEFs or human fibroblasts from patient B155 (p.Gln155*), both of 
which harbour protein-truncating mutations (Supplementary Fig. 7a,b,f,g). However, some 
residual staining was detected with the Abnova antibody raised to the entire DZIP1L protein, 
in both mutant cell types (Supplementary Fig. 7c,d and data not shown). Consistent with 
this, qRT-PCR showed reduced but not absent Dzip1l expression in Dzip1lwpy/wpy MEFs, 
with no compensatory change in Dzip1 (Supplementary Fig. 7e). Immunoblotting with the 
Abnova antibody revealed a band at the predicted size of DZIP1L in control but not B155 
human cells, confirming a lack of full-length protein in mutant cells (Supplementary Fig. 
7h). While we cannot rule out the possibility that the truncated mouse and human DZIP1L 
proteins retain some function, both would lack significant functional domains.
Cilia number is largely unaffected in Dzip1l mutant tissue
In early passage cultures, serum-starved B155 mutant human fibroblasts displayed no 
obvious difference to controls in the percentage of ciliated cells, cilia morphology or 
localization of a number of markers of cilia and basal bodies (ARL13B, acetylated-α-
tubulin, CEP164, DZIP1, and TCTN1; data not shown). However, in MEFs we consistently 
observed a decrease in the percentage of ciliated cells in serum-starved Dzip1lwpy/wpy versus 
control cultures (Supplementary Fig. 8a). Interestingly, in a number of embryonic mouse 
tissues, including the limb bud mesenchyme, we saw no difference in the relative proportion 
of cilia between mutant and wild-type embryos (n=3; Supplementary Fig. 8b). The only 
location we saw evidence of fewer cilia was in the collecting duct dilatations in the 
Dzip1lwpy/wpy kidney (data not shown), but this is likely to be an effect of the dilatations 
rather than a cause.
We also saw no obvious primary cilia defects in dzip1l deficient zebrafish embryos (Fig. 
5a,b; data not shown). However, consistent with prominent expression of dzip1l in MCCs in 
kidney tubules, numbers of cilia bundles were consistently reduced in morphant and zygotic 
and maternal-zygotic dzip1l mutant embryos (Fig. 5c–e; data not shown).
DZIP1L associates with the ciliary transition zone protein SEPT2
To further explore a function for DZIP1L at the cilium, we used human DZIP1L as bait to 
screen for interacting proteins in yeast two-hybrid libraries of highly ciliated human tissues 
(testis, lung and brain). From all three libraries, SEPT2 was identified as a high confidence 
interactor of DZIP1L (Supplementary Table 2). Septins are cytoskeletal GTPases, and 
SEPT2 functions as part of the periciliary diffusion barrier at the transition zone2829. The 
interaction was verified by co-immunoprecipitation of epitope-tagged DZIP1L and SEPT2 
(Fig. 6a) from transfected HEK293T cells (Fig. 6b), and by co-IP of the endogenous proteins 
from RPE-1 cells (Fig. 6c–e). Moreover, immunostaining of human dermal fibroblasts 
showed co-localization of DZIP1L and SEPT2 at the ciliary base (Fig. 6f). In support of the 
specificity of the interaction, we were unable to detect interaction in co-IP experiments 
between transfected SEPT2 and several other transition zone (NPHS1, MKS1, B9D1) and 
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basal body appendage (CEP89) proteins. Likewise, we failed to detect any interaction 
between these proteins and DZIP1L (Supplementary Fig. 9).
To localize the domains in DZIP1L that interact with SEPT2, we generated a series of 
epitope-tagged N- and C-terminal deletion DZIP1L constructs, and tested their ability to 
associate with SEPT2 in co-IP assays (Fig. 6a). We found that all, except a C-terminal 
fragment (from aa 500 to the end of the protein), were able to interact with SEPT2 (Fig. 6b). 
Intriguingly, even a small fragment consisting of the N-terminal 165 amino acids and 
lacking the zinc-finger and the coiled coil domains (effectively mimicking the predicted 
truncation of DZIP1L in patient B155), retained the ability to interact with SEPT2. This may 
explain why we did not observe any alteration in SEPT2 localization at the transition zone in 
the B155 DZIP1L mutant human fibroblasts (Fig. 6g,h).
Loss of DZIP1L affects the localization of PKD proteins to the ciliary membrane
The cystic kidney phenotype caused by loss of DZIP1L led us to investigate the ciliary 
localization of the two ADPKD proteins PC1 and PC2 in DZIP1L mutant cells. Using an N-
terminal PC1 monoclonal antibody (7e12)30 (see Supplementary Fig. 10 for validation), we 
found that in Dzip1lwpy/wpy ciliated MEFs, PC1 was more frequently enriched at the 
proximal end of the axoneme compared to wild-type MEFs, which frequently showed PC1 
staining along the length of the axoneme (Fig. 7a–c). In control human fibroblasts we 
detected PC1 at the basal body and along the axoneme, whereas there was a reduction in 
PC1 accumulation along the ciliary membrane of fibroblasts from individual B155 (Fig. 7d–
f). PC2 ciliary membrane localization was similarly affected in B155 fibroblasts (polyclonal 
antibody to aa 349–361; see online methods for details and Supplementary Fig. 11 for 
validation) (Fig. 7g–i). This suggests that in the absence of correct DZIP1L function, the 
ciliary membrane distribution of PC1 and PC2 is compromised, possibly reflecting a defect 
in the barrier function of the transition zone. However, this is unlikely to be a generalized 
defect since the HH co-receptor smoothened (SMO) localizes normally along the axoneme 
in response to SAG treatment in Dzip1lwpy/wpy MEFs (Supplementary Fig. 11). While we 
also analysed the localization of FPC in human fibroblasts, in our hands two independent 
antibodies revealed prominent staining around the basal body as described previously8,9, but 
not along the axoneme. This pattern remained unaffected in cells from individual B155 (data 
not shown).
DISCUSSION
In clinical genetics, there is a strong demand for early and reliable diagnosis of ARPKD, 
which is only feasible by molecular genetic analysis. To date, PKHD1 has been thought to 
be the only gene responsible for ARPKD. We have now identified DZIP1L mutations in 
ARPKD, thereby describing a second locus for this disease. While the clinical 
manifestations in our patients were first detected prenatally or during early childhood, none 
showed perinatal demise, which affects about 30% of ARPKD patients with PKHD1 
mutations31,32. Mutations in DZIP1L are a considerably rarer cause of ARPKD than 
PKHD1 mutations, maybe due in part to the larger size of PKHD1 relative to DZIP1L. 
Furthermore, our limited data suggest that the region encoding the N-terminus of DZIP1L 
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may be more susceptible to mutations, a concept supported by in silico data that predict 
pathogenicity scores to decay towards the C-terminus (Supplementary Fig. 12). Although we 
have not screened large numbers of embryonically lethal patients, in view of homozygous 
truncating mutations in two of our patients we hypothesize that it is unlikely that DZIP1L 
mutations play a major role in this cohort. This is consistent with the birth of homozygous 
mutant outbred mice at expected frequencies. Despite the relatively rare occurrence of 
pathogenic DZIP1L mutations, ARPKD NGS diagnostic multi-gene panels should 
nevertheless target this gene.
Ultrasonographic patterns observed in our patients phenocopy PKHD1-linked ARPKD, with 
characteristic bilaterally enlarged, echogenic kidneys, poor cortico-medullary differentiation 
and multiple tiny cysts. Macrocysts are uncommon in infants, although they may be present 
with advanced clinical course. Renal failure is rarely a cause of neonatal demise in ARPKD, 
but renal function variably deteriorates over time. Most of our patients developed chronic 
renal failure during school age; end-stage renal disease (ESRD) occurred in four. However, 
most patients were younger than 20 years at the time of analysis, and the remaining may 
develop ESRD later in life. For PKHD1-linked ARPKD, 25% of non-perinatal patients 
required kidney transplantation by age 3233. Most of our patients developed arterial 
hypertension in the first years of life, which is typical for ARPKD. DPM with congenital 
hepatic fibrosis is another hallmark of ARPKD. We detected subtle early signs of DPM in 
Dzip1lwpy/wpy mice, with the absence of more severe liver pathology, including hepatic 
fibrosis, likely due to the early demise of these mice. We can only speculate from our 
findings in the mouse that hepatic defects might also be present in our patients.
Consistent with the human phenotype, Dzip1lwpy/wpy mutant mice display an early onset, 
progressive, cystic kidney phenotype, with cysts arising from the collecting ducts and 
proximal tubules. While ARPKD usually affects the collecting ducts and distal tubules, 
individuals may present with involvement of other nephron segments, including proximal 
tubules34 (and unpublished data, CB). Moreover, a number of Pkhd1 mouse models display 
proximal tubule cysts, although the phenotype in mice carrying different alleles of Pkhd1 is 
variable, and kidney involvement generally manifests later than in Dzip1lwpy/wpy 
mice35,36,37.
Unlike patients with DZIP1L mutations, Dzip1lwpy/wpy mouse embryos display a number of 
extrarenal dysmorphologies including limb and craniofacial defects. The amelioration of 
craniofacial phenotypes on crossing to an outbred background suggests that at least some of 
these differences may be due to genetic background, and indeed many ciliary-related 
phenotypes are subject to variation based on genetic modifying alleles38. It is not uncommon 
to see phenotypic differences between human and mouse models. For example, non-renal 
and hepatobiliary phenotypes have been reported in PKD mouse models, including 
craniofacial, cardiovascular and skeletal defects in homozygous Pkd1 mutant mice39,40. 
While we cannot exclude the involvement of DZIP1L mutations in syndromic ciliopathies, 
pathogenic mutations have not been detected in large cohorts of ciliopathy patients screened 
to date. However, our data raise the possibility that variation at DZIP1L may genetically 
interact with other PKD or ciliopathy loci to modify phenotype.
Lu et al. Page 9
Nat Genet. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Our zebrafish analysis also supports a role in the kidney, with reduced motile cilia in dzip1l-
deficient pronephric tubules. Although the mammalian kidney is populated by primary cilia, 
this nevertheless suggests a conserved requirement of Dzip1l at cilia for proper kidney 
function across the vertebrates. It is notable that although dzip1l morphant and mutant 
embryos exhibited overlapping phenotypes (for example, otolith and motile cilia defects), 
we failed to observe body curvature and hydrocephalus in either zygotic or maternal-zygotic 
mutants. These effects could be morpholino-induced artefacts. However, given that all four 
morpholinos produced these phenotypes, it is possible that a degree of genetic compensation 
is operating in the mutants, as recently described41,42.
Our data suggest context or tissue-specific roles for DZIP1L in primary ciliogenesis and HH 
signalling in the mouse, whereas loss of the protein in zebrafish causes less prominent 
effects on these processes. Previous studies in cultured human cells suggested a redundant 
role for DZIP1 and DZIP1L in ciliogenesis17, a conclusion supported by our zebrafish in 
vivo experiments (data not shown). DZIP1 localizes to the basal body, the transition zone, 
and mother centriole22,43. Our findings reveal a similar localization pattern for DZIP1L, and 
proteomic studies in Chlamydomonas reinhardtii further support DZIP1L as a transition 
zone protein44. There is some debate over the precise boundaries between the basal body, 
transition zone and axoneme6, and some proteins shuttle between these structures. In 
keeping with a transition zone localization, we found that DZIP1L associates with SEPT2, a 
component of the transition zone diffusion barrier. While DZIP1L has not been rigorously 
associated with any of the known transition zone protein complexes, a recent mass 
spectroscopy study included DZIP1L amongst an extensive list of proteins pulled down by 
Inturned, a core component of the CPLANE transition zone complex that recruits a subset of 
intraflagellar transport A (IFT-A) proteins to basal bodies45. Although this raises the 
possibility that DZIP1L may act in the CPLANE complex, this requires further detailed 
analysis.
Consistent with a role for DZIP1L at the transition zone, ADPKD proteins PC1 and PC2 
showed altered distribution along the ciliary membrane in the absence of correct DZIP1L 
function. In the renal tubules, PC1 and PC2 act in a ciliary membrane complex, and FPC has 
been shown to bind to and regulate PC212. However, we were not able to detect FPC along 
the ciliary axoneme to determine if this localization was also compromised by loss of 
DZIP1L function. In terms of how ciliary mislocalization of the polycystins may contribute 
to PKD, it has been proposed that the PC1/2 complex suppresses a yet to be identified cilia-
dependent cyst formation signal that is inappropriately activated when the PC1/2 complex is 
unable to properly traffic to cilia46. Whether mislocalization of the polycystins is a major 
factor contributing to PKD in DZIP1L mutant mice and humans remains to be determined. 
Nevertheless, our data demonstrate DZIP1L dysfunction as a novel cause of ARPKD, and 
extend our understanding of the genetic heterogeneity underlying the pathology of this 
disorder.
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(ONLINE) METHODS
Ethics approvals
Human blood samples for DNA extraction and fibroblasts were obtained with written 
informed consent. All investigations were conducted according to the Declaration of 
Helsinki, and the study was approved by the Institutional Review Board of the Ethics 
Committee of the University Freiburg, University of Aachen, University of Michigan, 
Boston Children`s Hospital and collaborating institutions. All mouse experimentation was 
performed under approval from the Institutional Review Board of Australian National 
University and the relevant animal ethics committee of The University of Queensland, and 
conformed to ethical guidelines. All experiments involving zebrafish were approved by the 
animal committees of respective institutes (Regierungspräsidium Baden-Württemberg and 
the Singapore National Advisory Committee on Laboratory Animal Research).
Data availability
For data release, for each of the families the respective IRB-related protocols are being 
followed. Sequence and variant data will be deposited into dbGaP as a suitable public 
repository (https://www.ncbi.nlm.nih.gov/gap).
Human haplotype analysis and SNP genome-wide linkage analysis (homozygosity 
mapping)
Initially, linkage to PKHD1 was excluded by haplotype analysis. Two informative flanking 
markers were typed in our index pedigree B16. DNA samples were available from parents 
and all affected individuals. Primers for PCR amplification were as published before and are 
available on request. Microsatellite markers were analyzed on an ABI PRISM 3130 genetic 
analyzer (Applied Biosystems, Darmstadt, Germany). Subsequently, we performed genome-
wide SNP mapping in the above first-degree consanguineous index family with three 
affected children (LOD score 2.4; Fig. 1) and family A3533 as reported previously47.
DZIP1L mutation analysis
Mutation analysis was done by direct sequencing for the 15 exons encoding the 767 amino 
acid (aa) DZIP1L protein (GenBank: NM_173543.2, NP_775814; mutation numbering 
corresponds to the A of the ATG-translation initiation codon in exon 2). Genomic DNA from 
an affected individual was amplified by PCR with oligonucleotide primers complementary 
to flanking intronic sequences. Primers used for PCR and direct sequencing are available on 
request. Samples were run and analyzed on an ABI PRISM 3130 genetic analyzer (Applied 
Biosystems).
In addition to conventional Sanger sequencing of DZIP1L in a total of 218 patients with 
suspected PKD, we performed different next-generation sequencing (NGS) based 
approaches. First, we used PCR-based 48.48 Access Array microfluidic technology 
(Fluidigm™) with consecutive NGS. We applied a multiplexing approach allowing PCR-
based amplification of 53 amplicons (44 exons) for 48 DNA samples simultaneously in one 
known and two candidate genes, including DZIP1L. A total of 96 patients with a PKD-
related phenotype were analyzed. After two rounds of amplification followed by indexing of 
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all patient-derived products with 96 different 10 bp-barcodes in a subsequent PCR, 2×150 
bidirectional sequencing was performed on a MiSeq platform (Illumina™). Second, all 
exons and adjacent intronic boundaries of a different number of genes (dependent on the 
version of our customized multi-gene panel, including DZIP1L) known or hypothesized to 
cause PKD and other ciliopathies were targeted by a custom SeqCap EZ choice sequence 
capture library (NimbleGen, Madison, Wisconsin, USA) and subsequently sequenced on a 
Roche 454 GS FLX or an Illumina MiSeq or HiSeq platform (2×150 PE) according to the 
manufacturer’s protocol. A total of 1234 patients with a polycystic kidney disease phenotype 
(n=429) or an NPHP-related complex ciliopathy (n=805) were analyzed with an average 
coverage of 60-fold (GS FLX), 120-fold (MiSeq) or more than 200-fold (HiSeq), 
respectively. Bioinformatic analysis was performed using the Roche GS Reference 
Mapper™ software (v2.6), SeqPilot SeqNext moduleTM (v3.5.2, JSI medical systems, 
Kippenheim, Germany) as well as an in-house bioinformatic pipeline. For all approaches, 
potential mutations were confirmed by Sanger sequencing and shown to segregate with the 
phenotype. No further mutation thought to be of pathogenic relevance for the disease 
phenotype was present among the patients described in this manuscript. Whole-exome 
sequencing (WES) and mapping of reads was carried out as previously described48,49.
Mouse strains and mutation detection
N-ethyl-N-nitrosourea (ENU) mutagenesis screening was performed at the Australian 
Phenomics Facility essentially as previously described 23, except that C3H was used as the 
mapping strain. Phenotypic screening was at 14.5dpc. The initial genome scan involved 
screening a pool of affected (C57BL/6xC3H) F2 mice and a pool of unaffected F2 mice with 
a set of ∼100 markers that are polymorphic between C57BL/6 and C3H mice and on average 
span the genome at 20Mb intervals. The allele specific SNP markers were designed using 
available software to amplify a subset of validated SNPs. SNP typing was performed using 
the Amplifluor kit (Chemicon). The individual DNA samples from each of the affected and 
unaffected F2’s were run with markers that showed possible linkage to the mutation. 
Following this approach, the wpy mutation was mapped to a 64Mb region on the mouse 
genome (GRCm38) on Chr 9 between 48804027 (rs3023210) and 112866211 (rs3679771). 
In this interval there are >900 genes (GRCm38). Eight genes were chosen as potential 
candidates and subjected to Sanger sequencing of all candidate exons +/−15bp, used an 
Applied Biosystems 3730xl capillary sequencer, using Big Dye Terminator (BDT) chemistry 
version 3.1 (Applied Biosytems). The raw trace files were analysed using Lasergene 
software (DNAstar) against the C57BL/6 mouse reference genome (NCBI). One mutation 
was identified in intron 19–20 of Kif9 102bp distal to exon 19 (T to C), however was 
unlikely to be causal. Subsequent whole exome sequencing, as previously described50, was 
performed on samples enriched for exonic sequences by Nimblegen solution-based capture 
technologies, using the Illumina GAIIx system employing 100bp end reads. This resulted in 
the identification of 8 homozygous mutations of which only that in Dzip1l lay within the 
previously mapped critical interval. The mutation in Dzip1l was confirmed using affecteds 
and unaffecteds from the mapping screen run with an amplifluor assay designed to the 
Dzip1l SNV, and also by Sanger sequencing at the Australian Genomic Research Facility. 
Subsequently, a PCR and restriction enzyme-based genotyping assay was developed (details 
available on request).
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For detailed phenotypic analysis, C57BL/6:C3H mice were subsequently crossed to 
C57BL/6 wild-type mice through 5 generations (total of 7 wild-type crosses from G0 
mutagenised founder), promoting removal of incidental ENU-induced mutations. A pure 
C57BL/6 line was also maintained by reviving a frozen G1 C57BL/6 individual and crossing 
through 9 generations with wild-type C57BL/6 mice. The initial analysis of the 
Dzip1lwpy/wpy phenotype was performed on the C57BL/6:C3H mixed background following 
at least 2 backcrosses, and was broadly consistent in subsequent generations and also on the 
C57BL/6 pure background in all generations. All data presented on the outbred CD1 
background follows at least 4 crosses to CD1 (in total this line has now been crossed to CD1 
through 10 generations). On all background strains the overall phenotype has segregated 
with the Dzip1l mutation through many meioses (with amelioration of the craniofacial 
phenotypes on crossing to a CD1 background). In most cases wild-type littermates were 
used as controls, except in those cases stated where heterozygous embryos were used 
(Dzip1lwpy/+ heterozygous mice display no discernible morphological differences from 
wild-type).
Antibodies, stains and primers
Primary antibodies: mouse anti-ARL13B and rabbit-anti-ARL13B (NeuroMab, Clone 
N295B/66; 1:300 dilution for immunofluorescence (IF) and ProteinTech Group. #17711-1-
AP; 1:500 for IF); rabbit-anti-α-tubulin (Sigma-Aldrich T5192; 1:500 for IF); rabbit-anti-
acetylated-α–tubulin (Cell Signalling Technology #5335; 1:800 for IF); mouse-anti-
acetylated-α–tubulin (Sigma-Aldrich 6-11B-1; #T 6793; 1:500–700 for IF); mouse-anti-γ-
tubulin (Sigma-Aldrich T6557; 1:500 for IF), rabbit-anti-DZIP1L (Sigma-Aldrich 
#HPA030404; 1:500 for IF); mouse-anti-DZIP1L (Abnova-MaxPab H00199221-B01P; 
1:500 for IF; 1:1000 for western blot); rabbit-anti-DZIP1 (Proteintech Group, #13779-1-AP; 
1:500 for IF); rabbit-anti-SEPT2 (Sigma-Aldrich, #HPA018481;1:2000 for western blot; 
1:500 for IF); rabbit-anti-CEP164 (SAB3500022; Sigma), rabbit-anti-TCTN1 (ProteinTech 
Group, #15004-1-AP; 1:500 for IF); mouse-anti-Polycystin 1 (Abcam, #AB74115; Santa 
Cruz Biotechnology, # sc-130554; 1:200 for IF); rabbit-anti-Polycystin 2 (MV12; gift from 
R. Witzgall; 1:500 for IF); rabbit-anti-FPC (PKHD1)9 (hAR-Np and hAR-c2P; gift from G. 
Wu; 1:10 and 1:20, respectively); rabbit-anti-SMO51 was a kind gift of Rajat Rohatgi 
(Stanford University; 1:500 for IF); rabbit-anti-IFT88 (Proteintech 13967-1-AP; 1:300 for 
IF); anti-Aquaporin 2 antibody (Millipore; Cat # AB3274; 1:200 for IF); rabbit-anti-β-
catenin antibody (Abcam, #AB6302; 1:500 for IF); goat-anti-HNF3β (M-20) (Santa-Cruz, 
#sc-6544; 1:50 for IF); goat-anti-SHH(N-19) (Santa-Cruz, #sc-1194; 1:100 for IF); the 
mouse monoclonal antibodies for Isl-1 (1:200 for IF), Pax6 (1:10 for IF) and Nkx2.2 (1:50 
for IF) were obtained from the Developmental Studies Hybridoma Bank (developed under 
the auspices of the NICHD and maintained by The University of Iowa, Department of 
Biology, Iowa City, IA 52242.Bank); biotinylated Lotus Tetragonolobus Lectin (LTL) 
(Vector laboratories; Cat # B1325; 1:200). Secondary antibodies (all used at 1:500 for IF): 
Alexa 488 goat anti-rabbit (Invitrogen A-11034); Alexa 488 goat-anti mouse (Invitrogen 
A-11029); Alexa 555 goat anti-rabbit (Invitrogen A-21428), Alexa 594 goat anti-rabbit 
(Invitrogen A-11037); Alexa 594 goat anti-mouse (Invitrogen A-11032). Primers used in this 
study are presented in Supplementary Table 3.
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Mouse skeletal preparations, in situ hybridization, scanning electron microscopy and 
histology
Mouse skeletal preparations52, whole mount in situ hybridization53 and probes used in the 
limb54 have been described previously. Anti-sense RNA probes were prepared by 
transcribing linearized cDNA clones with SP6 and T7 polymerases using the digoxigenin 
labeling mix (Roche). Scanning electron microscopy methods and preparation of mouse 
tissues for histological analysis have been described previously55. For histological analysis, 
sections were stained with haematoxylin and eosin (H&E), Elastica van Gieson (EvG) or 
Silver using standard procedures.
Cell culture
Control and mutant MEFs were isolated from trunks of 13.5dpc littermate embryos by 
standard methods56 and cultured as primary cell lines for up to 5 passages in Dulbecco’s 
Modified Eagle Medium (DMEM, Invitrogen) containing 10% fetal bovine serum (FBS). 
Mouse inner medullary collecting duct (IMCD3) cells were grown under the same 
conditions. Human dermal fibroblasts were derived from skin biopsies from ARPKD 
affected individual B155 and age- and sex-matched control individuals using standard 
techniques. Human fibroblasts and HEK293T cells were maintained in DMEM (Sigma, St. 
Louis, IL, USA) with 4500 mg/L glucose and 10% FBS (HyClone, SH30071.03HI). RPE-1 
cells and RPE-1 cells with stable expression of ARL13B-GFP were cultured in ATCC 
formulated DMEM:F12 Medium (Catalog No. 30–2006) with 10% FBS and 0.01 mg/ml 
hygromycin B. Cultures of immortalized mouse kidney cells from heterozygous Pkd1flox/− 
and Pkd2+/− mice as well as Pkd1−/− and Pkd2−/− null mutant cells (derived by inactivating 
the flox allele with Cre recombinase via transfection in the case of Pkd157 and via 
spontaneous in-vivo conversion for Pkd258,59) (gifts of S. Somlo) were cultured in DMEM 
containing 2% fetal bovine serum (FBS), 10,000U/µl IFNγ, 10mg/L Insulin, 6.7µg/L 
Selenium, 5.5mg/L Transferrin and 1.2ug/L Triiodo-L-thyronine. Established cell lines, 
human fibroblasts and primary MEFs tested negative for mycoplasma.
IF analysis of mouse and human cells and mouse tissue sections
For IF analysis, cells were grown on glass coverslips to approximately 80%-90% confluency 
in DMEM + 10% FBS, at which time the medium was replaced with DMEM containing 
0.2% FBS for 24h or 0.1% FBS for 48h to induce ciliogenesis. For analysis of SMO the 
reduced serum media was supplemented with SAG (100nM, Alexis Biochemicals) or diluent 
alone for 24h. For cell cycle analysis cells were synchronized by serum starvation as above 
for 24h, the media was replaced with DMEM + 10% FBS and cells were fixed at different 
timepoints to optimize capture of cells at different stages of the cell cycle. Cells were fixed 
in either ice-cold methanol for 5 minutes (co-localization experiments involving Abnova 
anti-DZIP1L and PC2 antibodies) or 4% paraformaldehyde (PFA) for 10 minutes. PFA fixed 
cells were permeabilised in PBTX (PBS, 0.1% Triton X-100) for 10 minutes. Fixed cells 
were washed in PBS, and incubated with 2% bovine serum albumin in PBS for 1 hour, 
followed by 1 hour with primary antibody. After brief washes in PBS, cells were incubated 
with secondary antibody for 1 hour, and 10 minutes wash with 6-Diamidino-2-Phenylindole 
(DAPI) to stain nuclei, and mounted on glass slides with Dako Fluorescence mounting 
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medium and imaged on a Zeiss LSM-710 or Olympus FluoView upright laser scanning 
confocal microscope with a 63x or 100x objectives. For acquisition of 3D structured 
illumination superresolution microscopy (3D-SIM) images the sample preparation was 
modified to use high-precision coverslips (#1.5H) and VectaShield H-1000 mounting media 
(Vector Laboratories) in an effort to minimise spherical aberration. 3D-SIM was performed 
using a DeltaVision OMX v4 Blaze microscope (GE Healthcare) equipped with 488, 568 
and 647 nm lasers, and BGR-FR filter drawer as previously described60.
IF of embryo sections was performed as previously described61. For quantification of cilia in 
limb sections, three confocal Z-stacks were performed in each of 3 different sections from 
the limb (9 stacks in total per limb). Given the density of cells in the tissue, and to attempt to 
account for orientation of cilia in different planes, nuclei were manually counted from the 
third image of each 5-image stack, while cilia were counted from all 5. Note that the final 
cilia/nuclei ratio does not necessarily represent the actual percentage of ciliated cells in the 
tissue, but is a relative value across the samples. The same conclusion was obtained from 
counting both nuclei and cilia from just the third image of each stack.
Quantitative real time RT-PCR (qRT-PCR)
MEFs were cultured in DMEM containing 10% FBS to 80% confluency, before replacing 
with DMEM+0.2% FBS for 24h. For SAG treatment experiment, the reduced serum media 
was supplemented with SAG (100nM, Alexis Biochemicals) or diluent alone for 24h. Total 
RNA was extracted using TriReagent (Sigma-Aldrich), and first-strand cDNA synthesis was 
performed using SuperScript III First-Strand Synthesis system (Invitrogen) using oligo dT 
primers. cDNA was amplified with ABI SYBR Green PCR master mix using transcript 
specific primers (Supplementary Table 3). Temperature cycling and real-time detection of 
SYBR Green fluorescence used an Applied Biosystems 7900HT Fast Real-Time PCR 
system. Technical triplicate reactions were performed for each sample (gene of interest and 
normalising gene). Relative transcript levels were determined using the 2−ΔCT method.
Zebrafish strains and maintenance
Zebrafish (Danio rerio) were raised under standard conditions at 28°C. TU and AB wild-
type embryo strains were used and staged according to Kimmel62. The Tg(wt1b::GFP) strain 
has been described previously26.
Zebrafish embryo microinjections
Morpholinos were synthesized by Gene Tools and re-suspended in water at a stock 
concentration of 1mM. Morpholinos were injected into one- to two-cell stage eggs, with 
each morpholino injected at least four times for each analysis. The following volumes of 
morpholinos were injected: 1.5nl of translation blocking morpholino (0.25mM working 
solution), i1e2 morpholino (0.05mM), i4e5 morpholino (0.35mM) and 0.75nl e5i5 
morpholino (1mM). For rescue experiments, sense mRNAs of zebrafish and human DZIP1L 
(in the pSP64T or pCS2 vectors) were in vitro transcribed using the mMessage mMachine 
kit (Life technologies). For rescue of dzip1l morphants, embryos were co-injected with 
zebrafish dzip1l mRNA (100ng/µl).
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RT-PCR and in situ hybridization with zebrafish embryos
Zebrafish total RNA was isolated by Trizol (Ambion Life Technologies, # 15596018). RT-
PCR was carried out using one-step RT-PCR kit (QIAGEN,# 210212). 1µg of total RNA 
from each experimental group was used to synthesize the 1st strand cDNA. dzip1l specific 
primers were used to check mis-splicing induced by the morpholinos. actinb1 and ef1α RT-
PCR product levels were used as loading control. Whole mount in situ hybridization with 
the zebrafish dzip1l, ptc1, eng1a and nkx2.2b antisense mRNA probes was performed 
according to standard protocols.
Whole-mount IF staining of zebrafish embryos and confocal microscopy
Zebrafish embryos were fixed in Dent’s fixative (80% methanol, 20% DMSO) for 3 hours or 
4% paraformaldehyde for 2 hours at room temperature, followed by storing in absolute 
methanol at −20°C. Embryos were then rehydrated in a decreasing methanol:PBS gradient. 
Blocking buffer (1% (w/v) BSA, 1% DMSO, 0.5% Triton X-100 and 2% sheep serum in 
PBS) was used to block the embryos for 1 hour. The embryos were then incubated with 
primary antibodies at 4°C over-night. After washing embryos with PBDT (1% (w/v) BSA, 
1% DMSO, 0.5% Triton X-100 in PBS), the embryos were then incubated in fluorophore-
conjugated secondary antibodies and DAPI for 3 hours at room temperature. The stained 
embryos were mounted in 70% glycerol and imaged by confocal microscopy. Image 
acquisition and analysis was performed using the Olympus FluoView FV10-ASW software 
and an Olympus FluoView upright confocal microscope.
Generation of dzip1l CRISPR mutants
Design of sgRNAs: sgRNAs for the dzip1l gene were designed using the web tool 
CHOPCHOP63. Target sites for the sgRNAs were designed by seeking sequences 
corresponding to the GGN18NGG sequence in the DNA. Two sgRNAs, targeting exon 2 and 
exon 13, respectively, were designed. To check off-target effects of the sgRNAs, basic local 
alignment search tool (BLAST) was used and the results were visually analysed. Off-target 
sequences with no mismatches in the last 15 nt, including the NGG PAM, were discarded. 
Synthesis of sgRNAs: sgRNAs were synthesized based on a modified two-component 
system described by Bassett and colleagues64. Briefly, PCR was performed with a forward 
oligonucleotide encoding the T7 polymerase binding site and the sgRNA target sequence 
and a common reverse oligonucleotide encoding the remainder of the sgRNA sequence 
using Phusion polymerase (NEB, M0530S) (see Supplementary Table 3 for the 
oligonucleotide sequences). In vitro transcription was performed using 250ng of the purified 
DNA template with MEGAshortscript T7 kit (Ambion, AM1354M) and the sgRNAs were 
purified as per manufacturer’s instruction. Micro-injection of zebrafish eggs: A mixture of 
800ng of the Cas9 protein (Toolgen) and 500ng of each sgRNA were incubated at 37°C for 
15 minutes. One-cell stage embryos were injected with 1 nl of the mixture. Genomic DNA 
extraction and PCR analysis to identify mutations: Genomic DNA extraction from embryos 
and fins from adult fish were done using the alkaline lysis method65. For embryonic 
genomic DNA extraction, 8–10 single embryos at 2 dpf were used. To identify the 
mutations, primers were designed to bind upstream and downstream of the expected double-
stranded breaks in exon 2 and exon 13 (Supplementary Table 3). The PCR amplified 
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genomic DNA region from the mutants were TOPO-cloned and sequenced to confirm the 
deletion.
Yeast two hybrid screen, immunoprecipitation and western blot
Yeast two hybrid screen with human DZIP1L protein (three fragments: aa 1–232, 200–540 
and 540–767) was performed by Myriad pharmaceuticals. For immunoprecipitation of 
endogenous DZIP1L and SEPT2 and vice versa, RPE-1 or HEK293T cells were lysed in 
1ml of cell lysis buffer (20mM Tris at PH 8.0, 137mM NaCl, 1%Triton X-100, 2mM EDTA 
in PBS) with proteinase inhibitor cocktail (Roche, Switzerland). Protein concentrations were 
estimated by using Bio-Rad protein assay reagent (BioRad Laboratories, USA) according to 
the manufacturer’s instructions and reading the absorbance at 595 nm with a 
spectrophotometer. Equal amounts of total protein lysates (0.5mg-10mg) were incubated 
with DZIP1L or SEPT2 antibodies (2µg) and protein A-agarose (Oncogene Research 
Products, USA) overnight at 4°C. The immunoprecipitates were washed 5 times with cell 
lysis buffer, boiled in Laemmili buffer for 5 min and resolved by SDS-PAGE. For western 
blot analysis, cells were lysed in RIPA buffer (50mM Tris-HCL, pH7.2, 150mM NaCl, 1% 
Triton x-100, 1% (w/v) deoxycholic acid, 0.1% (w/v) sodium dodecyl sulphate, 0.25mM 
EDTA with proteinase inhibitor cocktail). The proteins in the lysate were separated by SDS-
PAGE. For interaction of SEPT2, different DZIP1L constructs and NPHP1, MKS1, B9D1 
and CEP89, transient transfections into HEK293T cells were carried out using 
JetPrimePolyPlus transfection kit (PolyPlus Transfections) according to the manufacturer’s 
instructions. Cell lysates were prepared in lysis buffer (20mM Tris-HCl, pH7.4, 150mM 
NaCl, 1mM EDTA, 0.25% deoxycholate, 1% NP-40 and protease inhibitors). ImmunoCruz 
IP/WB Optima C beads (Santa cruz Biotechnology INC) were incubated with 2µg of M2 
FLAG antibody (F1804; Sigma) for 3 hours at 4°C and subsequently washed in lysis buffer. 
Control and transiently transfected cell lysates were added to the antibody-beads conjugate, 
and incubated further overnight for 4°C. Immunoprecipitates were washed in lysis buffer, 
separated by SDS PAGE, transferred onto PVDF membranes and probed with rabbit anti-
HA antibodies (77–5500; Thermo Fisher Scientific) followed by goat-anti rabbit-HRP 
secondary antibody (Biorad) and chemiluminescence (Super Signal West Pico; Thermo 
Fisher Scientific).
Alignment of DZIP1L amino-acid sequences
Human, mouse and zebrafish DZIP1L sequence alignment was performed using the 
MegAlign software (DNASTAR Lasergene 12 Core Suite) following the Clustal W Method.
Statistical analyses
Statistical analyses used Prism version 4.0, 6.0 or 7.0 software (Graphpad). In most cases P-
values are based on an unpaired Student’s t-test (see figure legends for details), the mean 
value is shown and error bars represent standard error of the mean (SEM). In these cases 
variances are not significantly different. The exception is the analysis in Fig. 3m where both 
the sample sizes and variances are unequal, and an unpaired t-test was used with Welch’s 
correction. The significance in this case was confirmed by a Student’s t-test on log 
transformed data where the variances are equalized (not shown). For animal experiments no 
specific randomization or routine blinding strategies were employed. Regardless of whether 
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statistical tests were applied, as per standard practice, all animal experiments were 
performed on multiple embryos/mice/morphants or primary cell lines derived from multiple 
independent embryos. For both mice and zebrafish the number of individuals used in each 
experiment is detailed in the text and/or relevant figure legend.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Mapping of a new ARPKD locus on 3q22.1-q23 and identification of DZIP1L mutations. 
Genome-wide SNP analysis performed in two unrelated consanguineous multiplex pedigrees 
(shown at top) with a total of five children affected by ARPKD, resulted in identification of 
a single overlapping 7.5 Mb region of homozygosity on chromosome 3q22.1-q23. By 
various sequencing approaches, we identified different homozygous DZIP1L mutations in 
these and other consanguineous families with ARPKD (see text for details). In parallel, we 
identified an ENU-induced recessive mouse model (see Fig. 2) bearing the homozygous 
Dzip1l nonsense mutation c.1123C>T (p.Gln375*) (in blue).
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Figure 2. 
Dzip1lwpy/wpy mutant embryos show multiple dysmorphic features. (a) Control (left) and 
mutant (right) embryos at 17.5dpc. (b–e) Skeletal preps at 17.5dpc highlight defects in the 
craniofacial complex and polydactyly in Dzip1lwpy/wpy embryos (c,e) relative to controls 
(b,d). Dzip1lwpy/wpy mutant embryos consistently show some degree of cleft palate (f,g; 
arrowhead in g) and bilateral cleft lip (f-i; arrows in g,i). Scanning electron micrographs of 
15.5dpc embryos shown with lower jaw removed in f,g; 13.5dpc embryo heads in h,i. (j,k) In 
a subset of embryos (n=30/45 scored) the eyes appeared abnormal, and in severe cases were 
buried within the skull (arrow in k). Images shown are of frontal sections through 15.5dpc 
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embryonic heads. Note control embryos shown in (b,f,j) are heterozygous embryos that 
show no obvious phenotypic differences from wild-type controls, as shown in (a,d,h). The 
limbs shown in (d,e) are from different embryos than those shown in (b,c). Scale bars in 
a,b,c = 2mm; d,e = 0.5mm; f-k = 1mm. All data presented are from embryos on a C57BL/
6:C3H mixed background.
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Figure 3. 
Dzip1lwpy/wpy mice display progressive cystic kidney disease and hepatic defects following 
at least 4 crosses to a CD1 background. (a,b) Following H&E staining, cortical cysts were 
evident from 15.5dpc in Dzip1lwpy/wpy kidneys (arrow in b; n=4 independent embryos). 
(c,d,g,h) At P0, both cortical cysts (arrowhead in d,g) and medullary dilatations (arrow in 
d,h) were observed (n=6). (g,h) Show high power images of the regions marked in (d). 
(e,f,i,j) Immunofluorescence analysis of sections from P0 kidneys stained with Aqp2 
(collecting ducts; green), and LTL-biotin (proximal tubules; magenta). (i,j) Show high power 
images of the proximal tubule cyst (i) and collecting duct dilatation (j) marked with an 
arrowhead and arrow respectively in (f). (k,l) By P21, cysts extend throughout the kidney, 
and (m) when corrected for body weight Dzip1lwpy/wpy kidneys are heavier than wild-type 
(n= 3 mutant, 4 wild-type embryos). Statistical analysis based on unpaired t-test with 
Welch’s correction to account for unequal variances, *p=0.05. Error bars show SEM. A 
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significant difference was confirmed with a Student’s t-test on log transformed data, where 
the variances are equalized (not shown). (n–q) H&E staining of P21 liver sections. Arrows 
mark an excess of bile ducts, which nearly circumferentially surround portal vein branches 
in P21 Dzip1lwpy/wpy mutant (o,q) compared to wild-type (n,p) mice, indicating DPM (n=2). 
Scale bars in a,b = 100µm; c-f = 200µm, k,l = 500µm and g-j and n-q = 50µm.
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Figure 4. 
DZIP1L localization overlaps with basal body, centrosome and transition zone markers. (a,b) 
IF staining for DZIP1L (green) and acetylated-α-tubulin and γ-tubulin (both in magenta) in 
serum starved IMCD3 kidney cells. DZIP1L staining overlaps with the basal body in ciliated 
cells (a) and the centrosome in non-ciliated cells (b). (c–d) Co-localization of DZIP1L 
(magenta) with the distal (CEP164, green in c) and subdistal (ODF2, green in d) appendage 
proteins. (e–i) DZIP1L (green) tracks with the centrioles (magenta) throughout all stages of 
the cell cycle in IMCD3 cells. (j) TCTN1 (magenta) and DZIP1L (cyan) co-localize at the 
transition zone in human dermal fibroblasts. ARL13B-GFP was used to mark the ciliary 
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membrane around the axoneme (green in j). (k) 3D-SIM superresolution microscopy on 
RPE-1 (human retinal pigment epithelial) cells confirms both DZIP1L (magenta) and 
TCTN1 (cyan) are closely associated at the transition zone. Cilium labeled with ARL13B-
GFP (green). Nuclei are stained with DAPI (blue). Scale bars in a-I = 5µm; j = 1µm; k = 500 
nm. DZIP1L stained with Sigma C-terminal antibody, except in panels c,d,j,k where the 
Abnova antibody was used.
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Figure 5. 
Dzip1l is required for ciliary differentiation in the zebrafish kidney tubule. (a) Primary cilia 
(short arrows; myotome) and mono motile cilia (long arrows; pronephric duct) in a 24 hpf 
wild-type embryo. (b) No obvious difference in primary (short arrows) and mono motile 
cilia (long arrows) differentiation in a dzip1l splice morpholino (e5i5) injected embryo at 24 
hpf (n=10). (c) MCC motile cilia bundles (arrows) in the pronephric duct of a wild-type 
embryo at 48 hpf (arrows). (d) MCC motile cilia bundles (arrows) are reduced in a 48 hpf 
maternal-zygotic dzip1l mutant zebrafish embryo (n=8). (e) Quantification of MCC cilia 
bundles in wild-type and maternal-zygotic dzip1l mutant zebrafish embryos. 8 embryos from 
each group were analyzed. **p=0.0017 based on unpaired Student’s t-test. Error bars show 
SEM. In all panels, cilia were stained with anti-acetylated tubulin antibody (magenta) and 
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nuclei with DAPI (blue); in panels a,b,f-i cell membranes were stained with β-catenin 
antibodies (green). Scale bars in a,b,f-i = 10µm; c,d = 100µm.
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Figure 6. 
DZIP1L associates with the ciliary transition zone protein SEPT2. (a) Schematic diagram of 
SEPT2, DZIP1L and a series of DZIP1L deletion mutants. (b) Interaction between SEPT2 
(N-terminal FLAG) and DZIP1L and various DZIP1L deletion mutants (C-terminal HA) as 
determined by IP following transfection in HEK293T cells. (c,d) Endogenous interaction 
between DZIP1L and SEPT2 in RPE-1 cells. IP was performed with either the anti-DZIP1L 
antibody (Abnova; c) or the anti-SEPT2 antibody (d). (e) Expression of DZIP1L and SEPT2 
in total cell lysate. (f) Co-localization of DZIP1L (cyan) and SEPT2 (magenta) in human 
dermal fibroblasts. ARL13B-GFP was used to mark the ciliary axoneme (green). (g,h) 
SEPT2 (green) localization to the transition zone was unaffected in DZIP1L mutant dermal 
fibroblasts from individual B155 (p.Gln155*). Ciliary axonemes and basal bodies were 
labelled with anti-acetylated tubulin and anti-γ-tubulin antibodies (magenta), respectively. 
Scale bars in f-h = 1µm. All co-IP experiments were repeated at least three times.
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Figure 7. 
Loss of DZIP1L affects the localization of PC1 and PC2 to the ciliary membrane. (a) In 
most wild-type ciliated MEFs PC1 (green; 7e12 mAb, Abcam) staining was distributed 
along the length of the axoneme as marked with ARL13B (magenta). (b) By contrast PC1 
staining was more often concentrated at the proximal end of the axoneme in Dzip1lwpy/wpy 
MEFs (c) Quantification of the percentage of ciliated cells with PC1 along the axoneme 
(n=6, derived from 3 MEF cell lines from independent embryos, each counted in two 
separate experiments; between 50–185 cells counted per replicate, total 737 Dzip1l+/+ and 
649 Dzip1lwpy/wpy cells counted). (d,e) Decreased PC1 (green) localization in the ciliary 
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membrane in human dermal fibroblasts from affected individual B155 (p.Gln155*). 
ARL13B (magenta) marks the ciliary axoneme. (g,h) Decreased PC2 localization (green) in 
the ciliary membrane in DZIP1L mutant human dermal fibroblasts. Acetylated-α–tubulin 
and γ-tubulin (magenta) mark the cilia. (f,i) Quantification of the percentage of ciliated cells 
with PC1 and PC2 along the axoneme, respectively, in control and DZIP1L mutant human 
dermal fibroblasts. For human cells, cilia were counted in three experiments, with cells from 
three independent coverslips counted for each experiment (approximately 100 ciliated cells 
counted on each coverslip). In all cases, quantification included cilia with or without 
detectable PC1 or PC2 staining. Statistical analyses based on unpaired Student’s t-test. Error 
bars show SEM. For PC1 staining on MEFs, ****p<0.0001; PC1 and PC2 staining on 
human dermal fibroblasts, ***p<0.001. Scale bars in a,b = 2µm; d,e,g,h = 1µm.
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